• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 6
  3. Author

Online ISSN: 2515-8260

Volume9, Issue6

Effect of anti-diabetic drugs on central macular thickness in patients with type 2 diabetes mellitus

    Dr. Sneha Pal, Dr. Priyanka Malik

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 6, Pages 643-647

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Aim: To compare central macular thickness (CMT) of diabetic patients with type 2 diabetes without clinical retinopathy and healthy subjects.
Material & Methods: This is a prospective study, carried out on 92 patients. The patients were divided in to two groups: study group included 50 patients and control group comprised of 42 patients.
Results: The mean HbA1c level was 8.68 ± 2.39% in the study group and 5.10 ± 0.76% in the control group. The mean level of HbA1c was statistically higher in the study group than in the control group (Table 1, P = 0.001). Fasting plasma glucose level was statistically higher in the study group than in the control group (P= 0.001).
Conclusion: Central macular thickness was not significantly thicker in patients with type 2 diabetes without clinical retinopathy than in healthy subjects
Keywords:
    Central macular thickness Type 2 Diabetes mellitus retinopathy
  • PDF (312 K)
  • XML
(2022). Effect of anti-diabetic drugs on central macular thickness in patients with type 2 diabetes mellitus. European Journal of Molecular & Clinical Medicine, 9(6), 643-647.
Dr. Sneha Pal, Dr. Priyanka Malik. "Effect of anti-diabetic drugs on central macular thickness in patients with type 2 diabetes mellitus". European Journal of Molecular & Clinical Medicine, 9, 6, 2022, 643-647.
(2022). 'Effect of anti-diabetic drugs on central macular thickness in patients with type 2 diabetes mellitus', European Journal of Molecular & Clinical Medicine, 9(6), pp. 643-647.
Effect of anti-diabetic drugs on central macular thickness in patients with type 2 diabetes mellitus. European Journal of Molecular & Clinical Medicine, 2022; 9(6): 643-647.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 49
  • PDF Download: 55
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus